Pharmaceutical treatments (NRTs)

P. Tønnesen (Gentofte, Denmark)

Source: ERS Course 2015
Number: 8
Disease area: Airway diseases

PDF journal article, handout or slidesSlide presentationWebcastMultimedia files

Rating: 4.5
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Tønnesen (Gentofte, Denmark). Pharmaceutical treatments (NRTs). ERS Course 2015

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
Pharmaceutical treatments (Varenicline)
Source: ERS Course 2015
Year: 2015

Pharmaceutical treatments (Bupropion)
Source: ERS Course 2015
Year: 2015

Safety, pharmacodynamics (PD) and pharmacokinetics (PK) of darotropium (DARO) and vilanterol (VI) in healthy subjects: Two phase 1 studies
Source: Annual Congress 2013 –Asthma and COPD drugs: efficacy, safety and pharmacoeconomics
Year: 2013

Pooled analyses of QTcF across six phase 2b studies with glycopyrrolate-formoterol fumarate (GFF) MDI (PT003), its components and active comparators
Source: Annual Congress 2013 –Clinical trials of LAMAs, LABAs, MABAs and theophylline for asthma and COPD
Year: 2013

Pharmaceutical Treatment
Source: Research Seminar 2007 - The limits to exercise in COPD: new insights from new methods
Year: 2007

Astro-Lab project: Assessment of the safety of long-acting beta agonists (LABAs) in asthma by combining health-care databases and direct patient follow-up: Description of the patient pattern in France and in the United-Kingdom (UK)
Source: Annual Congress 2013 –Treatment and adherence to treatment of respiratory disease
Year: 2013

Safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of single (SD) and repeat (RD) inhaled doses of a novel phosphoinositide 3-kinase δ inhibitor (PI3Kδ), GSK2269557, administered to healthy smokers
Source: International Congress 2014 – New drugs for asthma, COPD and pulmonary fibrosis
Year: 2014

Cost effectiveness of inpatient initiated varenicline tartrate (VT) plus counselling compared to counselling alone: 2 year follow-up of the Smoking Termination Opportunity for inPatients (STOP) study
Source: International Congress 2016 – Emerging issues in smoking cessation and tobacco products
Year: 2016

Oral corticosteroid prescription patterns for asthma in France, Germany, Italy and the UK
Source: Eur Respir J, 55 (6) 1902363; 10.1183/13993003.02363-2019
Year: 2020

Integrated analyses of phase II safety data support the safety of glycopyrrolate-formoterol fumarate (GFF) MDI (PT003) and glycopyrrolate (GP) MDI (PT001) in COPD
Source: Annual Congress 2013 –COPD drugs: new findings
Year: 2013

Treatment of tobacco addiction using the feeling-state addiction protocol (FSAP) of the eye movement desensitization and reprocessing (EMDR) treatment
Source: Annual Congress 2013 –Smoking cessation for healthy and non-healthy smokers
Year: 2013

The Innovative Medicines Initiative (IMI), a promising partnership to deliver new medicines to patients
Year: 2008

New oral anticoagulants (NOACs) vs. warfarin: Are doctors ready to switch?
Source: International Congress 2015 – New developments in medical education, web and internet
Year: 2015

Effectiveness of N-acetyl cyctein (NAC) to reduce cough when used together with other over-the-counter (OTC) in common cold (a preliminary study)
Source: Annual Congress 2008 - Advances in the treatment and pathogenesis of pulmonary diseases
Year: 2008

Effect of severe renal impairment (SRI) on umeclidinium (UMEC) and vilanterol (VI) pharmacokinetics (PK)
Source: Annual Congress 2013 –COPD drugs: new findings
Year: 2013

Hospitalisation costs for community-acquired pneumonia (CAP) in France (F), Germany (D), Japan (J) and USA
Source: Eur Respir J 2004; 24: Suppl. 48, 8s
Year: 2004

The impact of antimicrobial resistance on the cost-effectiveness of empirical treatment of community-acquired pneumonia (CAP) in France (FR), Belgium (BE) and Germany (DE)
Source: Annual Congress 2007 - Community-acquired pneumonia: from aetiology to complication
Year: 2007

Bupropion hydrochloride (Zyban™) is effective and well tolerated as an aid to smoking cessation - a multicountry study
Source: Eur Respir J 2001; 18: Suppl. 33, 11s
Year: 2001